1. The metabolic effects of p-aminophenol have been compared with those of paracetamol and other analgesics in studies of rat liver and kidney in vitro.
Introduction
Many patients abusing compound analgesics develop chronic renal disease. Its cause and course are poorly understood. Because patients are often seen with established renal failure, and analgesics have been taken for many years, it is assumed that the natural history of the disease is gradual and progressive. This may not be correct. The cortical component of the kidney lesion, interstitial nephritis, may follow acute tubular necrosis (Hollman & Wong, 1964; Green, Ham 8c Tange, 1969) . Little is known of the way in which analgesics produce renal damage. Individual analgesics are either not nephrotoxic, even in very high doses (Leonards, 1972; Phillips, Hartnagel, Leeling & Gurtoo, 1976) , or produce minor renal damage (Fordham, Huffines & Welt, 1965; Nanra & KincaidSmith, 1970 ) insufficient to cause renal failure.
Moreover, paracetamol, the major metabolite of phenacetin, is hepatotoxic (Dixon, Nimmo & Prescott, 1971) and not nephrotoxic. The hepatotoxicity of paracetamol has been investigated in detail (Gillette, 1974; JolIow, Thorgeirsson, Potter, Hashimoto & Mitchell, 1974) , and may be due to the formation of a toxic intermediate metabolite, which is very reactive chemically, and which accumulates in toxic concentrations only when primary meta-
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bolic pathways are already saturated. Formation of similar highly reactive intermediate metabolites of phenacetin can be deduced from the presence of certain minor metabolites in the urine (Nery, 1971; Calder, Creek & Williams, 1974) , and some related compounds which are highly nephrotoxic (Calder, Funder, Green, Ham & Tange, 1971 ) may be responsible for the supposed nephrotoxic effect of phenacetin. p-Aminophenol is chemically related to phenacetin and is a potent nephrotoxin. Even in small doses it produces necrosis of proximal convoluted tubules in rats, but animals survive quite large doses (Green et al., 1969) . Ultrastructural studies show changes in affected cells within 30 min of intravenous injection (Funder, Green, Ham & Tange, 1972) , and complete necrosis develops in some cells within 4 h. We aimed to determine if biochemical and functional changes accompany or precede the appearance of these lesions, by studying biosynthetic function and ATP in vitro in isolated rat liver cells and renal cortical tubules, and also measuring transport and metabolism in the isolated perfused kidney.
Methods

Animals
Male albino Wistar rats, weighing 250-350 g, were fed on a pellet diet (Labsure 41B) and starved for 24 h before experiments, being allowed access to water. Animals (six to eight in each group) were given (dose 3 mmol/kg) paminophenol, N-acetyl-p-aminophenol (paracetamol), phenazone or p-phenetidine [all as the hydrochloride, 1 mmol in 1 ml of HCI (1 molll)] or acetylsalicyclic acid [aspirin, as sodium salt : 1 inmol in 1 mI of NaOH (1 mol/l)], by tail vein under light ether anaesthesia. The volume of each injection was approximately 1 ml, given at 0.2 ml/min. Under these conditions, p-phenetidine was often fatal. Control injections of HCI or NaOH had no deleterious effects on the animals. Liver cells and renal tubules prepared from such animals gave the same rates of gluconeogenesis as those from control rats.
Both injected and normal animals were given intraperitoneal pentobarbitone (60 mg/kg) for preparation of isolated renal tubules or liver cells, or liver and kidney tissue for ATP determinations, or for isolated kidney perfusion.
Isolated tissues
Isolated renal tubules were prepared by a modification (Dr P. Vinay, personal communication) of previous methods (Guder, Wiesner, Stukowski & Wieiand, 1971) . Slices of renal cortex were incubated for 45 min in a 150 ml siliconized conical flask contaning 30 mg of hyaluronidase (EC 3.2.1.35) and 10 mg of collagenase (EC 3.4.24. 3) (Boehringer, Mannheim) in 10 ml of Krebs-Henseleit medium. The final suspension contained 15-30 mg dry weight of tubules/ml. Portions of suspension (0.5 ml) were added to 25 ml siliconized conical flasks containing 0.5 ml of 10% dialysed serum bovine albumin, 0.1 ml of substrate (0.2 mol/l:lactate, pyruvate etc.) and 0.9 ml of Krebs-Henseleit medium. The flasks were gassed with Oz/COz (95:5,v/v) for45 s, stoppered and then incubated at 37°C for 40 min in a shaking water bath at 90-100 oscillations/min. Reactionswere stopped by adding the contents of the flask to 0.5 ml of perchloric acid (1 mol/l). Dry weight of renal tubules was determined by evaporating duplicate 1 ml portions to dryness. No correction was made for the mineral weight of the suspending volume of medium; this results in a 5-10% over-estimate of the tissue dry weight. Test compounds were added in 2 or 4 mmol/l concentrations.
Liver cells were prepared by the method of Berry & Friend (1969) , as modified by Krebs, Cornell, Lund & Hems (1973) , portions of the suspension being incubated with substrate as for the isolated renal tubules. Test compounds in aqueous solution were added to preparations of liver cells from normal uninjected animals. Results were expressed as Bmol of productlg dry weight.
Isolated kidneys were perfused by the method of Nishiitsutsuji-Uwo, Ross & Krebs (1967) , as modified by Ross, Epstein & Leaf (1973) , via the renal artery with a medium consisting of 6.7% bovine serum albumin (fraction V) in Krebs-Henseleit medium. Substrate, either lactate (10 mmol/l) or glucose (5 mmol/l), was added before beginning perfusion, and perfusion was continued for 60 min. Glomerular filtration race (inulin clearance) was determined with [14CJinulin (Ross et al., 1973 
Experimnta I procedure
Tubules were prepared from a control and an injected animal and incubations were then carried out in parallel. Each of the procedures was tested separately for any effect on glucose synthesis in liver cells or tubules; injection of NaOH, HCI or exposure to ether were without effect and control values presented refer to animals which were not so treated. In experiments to determine the effect of added agents, tubules from single animals were incubated with or without the inhibitor.
Statistics
Comparisons were made by t-test ; results are presented as mean?^^^ (n = number of observations). When tubules or liver cells prepared from a single animal were exposed to different treatments, paired tests were applied.
Results
Isolated renal cortical tubules
The rate of gluconeogenesis from lactate and pyruvate ( in four pairs of animals. These differences were all highly significant (PiO.01). There was no such reduction after aspirin, phenazone, pphenetidine or paracetamol given intravenously in similar doses even though one of these drugs, p-phenetidine, produced intense methaemoglobinaemia. The apparently lower values for glucose synthesis in experiments with phenazone and aspirin (Table 1) did not differ from control studies on the same day.
Aspirin and paracetamol added directly to renal tubule preparations from control rats consistently reduced gluconeogenesis from both pyruvate and lactate by 20-30% (Table 2 ). pAminophenol added to renal tubule preparations interfered with the hexokinase assay for glucose, and so this effect was not further examined.
Liuer cells
In order to demonstrate that p-aminophenol was primarily nephrotoxic, the effect of this compound and some related compounds was examined in isolated liver cells. There was no reduction in the rate of glucose synthesis from lactate by isolated liver cells prepared 1 h after intravenous p-aminophenol (3 mmol/kg), but gluconeogenesis from pyruvate and alanine was reduced. Paracetamol injected intravenously (3 mmol/kg) also produced significant inhibition of glucose synthesis from pyruvate and alanine (P<O-O5) but not from lactate, but the results were variable (Table 3) . When paracetamol (4 mmol/l) was added to normal liver cell suspensions, gluconeogenesis from each sub-TABLE 2. Inhibition of gluconeogenesis in renal tubules by added aspirin or paracetamol Renal cortical tubules prepared from starved rats were incubated in the presence of either aspirin or paracetamol at the concentrations indicated below. Substrates were added at a concentration of 10 mmol/l. Results for glucose synthesis are expressed as m e a n k s m (with number of flasks in parentheses). P values refer to paired t-test. Liver cells were prepared at 60 min after injection, and from uninjected animals as control. Cells were incubated with the substrates indicated for 60 min. and the rate of glucose formation for the period 30-60 min was linear (see Krebs et al., 1973) . Results are presented for the rate of glucose formation . With the exception of the inhibition from fructose, these differences were significant (P < 0.05). Gluconeogenesis from lactate (10 mmol/l) was inhibited by 30% by concentrations of paracetamol as low as 0.5 mmol/l, and progressively inhibited by increasing concentrations of paracetamol. With paracetamol at 4 mmol/l, glucose synthesis from lactate fell from 142t12.5 pmol h-I g-I dry weight to 79.6k5.3 (n = lo), a highly significant difference (P<OOOl).
Isolated perfused kidney
When p-aminophenol was injected intravenously in rats (3 mmol/kg) 1 h before perfusion, flow rate and pressure were not altered but there was significant reduction of inulin clearance and sodium reabsorption (P < 0.001) in kidneys perfused with either glucose or lactate as substrate (Table 4 ). The significant reduction in total tubular sodium reabsorption to only 2% of the control value was accompanied by much smaller effects on glucose and lactate metabolism. In contrast with the marked inhibition in isolated tubules the rate of gluconeogenesis from lactate was normal in three out of six perfusions, but was reduced by 20, 40 and 50% in the remainder. The rate of lactate production from glucose was increased in four out of six perfusions. The ATP content of kidney was invariably reduced. When the kidney was prepared for perfusion only 5 min after intravenous injection of p-aminophenol, normal values for glomerular filtration rate and sodium reabsorption were obtained.
Liver and kidney ATP content in vivo
The ATP content of kidneys freeze-clamped in vivo was 8.4 k 1 .O (n = 11) pmol/g dry weight.
Five minutes after intravenous injection of p-aminophenol ATP content remained normal (11.0+0-9, n = 7), but it was significantly reduced to 4.0 + 0.5 (n = 10) (P < 0.01) 1 h after F injection. ATP content of liver (9.4 k 1.1 ; n = 11) was unaffected by injection of paminophenol. Paracetamol given intravenously was without effect on ATP content either in kidney (11.9; n = 2) or liver (10-3; n = 2).
Discussion
Our studies demonstrate an effect of p-aminophenol on the proximal convoluted tubule of the kidney. Gluconeogenesis is restricted to the cortex and has recently been localized to the cells of the proximal convoluted tubule (Schmidt & Guder, 1976) . Substrates were selected (Krebs, 1964) to detect any inhibition of known ratelimiting enzymes of gluconeogenesis. Since paminophenol inhibited gluconeogenesis equally from all the substrates tested, it is unlikely that a specific enzyme in the pathway is the site of action of the compound or of its metabolite. The reduction in ATP content of the whole kidney 1 h after p-aminophenol might explain this observation since ATP is required for maximum rates of gluconeogenesis. The time taken to prepare isolated renal tubules, and for incubation with substrate, prevents measurement of gluconeogenesis at 5 min when amounts of ATP are still normal. The effects of intravenous p-aminophenol on the metabolism of isolated liver cells were different from those in isolated renal tubules. The maximum rate of gluconeogenesis from lactate was unaffected and hepatic ATP content was unchanged. The dramatic abolition of Na+ transport in the perfused kidney within 1 h of intravenous p-aminophenol is also consistent with severe damage to the proximal tubule. It is unlikely to arise directly from inhibition of gluconeogenesis, since other inhibitors of gluconeogenesis are known to be without effect on Na+ reabsorption (Ross, Frega & Leaf, 1975; Ross & Bullock, 1976) , but may result from the low tissue ATP content, especially in the proximal tubule. Impaired oxidative metabolism is suggested by an increased rate of lactate production from glucose. The reduction in glomerular filtration rate is more difficult to explain. A significant glomerular morphological lesion is not found at any time after intravenous p-aminophenol (Green et al., 1969; Funder ei al., 1972) . Moreover, in the perfused kidney, flow rate of medium (plasma flow) was constant and the reduction of glomerular filtration rate and Na+ The effects ofp-aminophenol upon the kidney and liver are observed after intravenous injection; in this respect p-aminophenol differs from aspirin, which affects gluconeogenesis only when added directly to renal tubule suspensions. Aspirin inhibition of glucose synthesis from lactate, pyruvate or other substrate (Dawson, 1975) is minor, and comparable with that seen with salicylate (2 mmol/l) in the isolated perfused rat liver (Woods, Stubbs, Johnson & Alberti, 1974) . The effect on liver is not associated with morphological changes.
The effects ofp-aminophenol are very different from those of paracetamol. Overdoses and high experimental doses of paracetamol produce liver necrosis (Dixon et al., 1971 ) and this has been related to the formation of a highly active toxic metabolite, which, after glutathione depletion, binds to liver cell thiol groups (Gillette, 1974) .
In the present experiments gluconeogenesis by isolated liver cells was depressed by paracetamol added in concentrations as low as 0.5 mmol/l. This may suggest a hepatotoxic effect separate from that described by Gillette (1974). Record, Iles, Cohen & Williams (1976) report lactic acidosis as a late effect of paracetamol in man, which is consistent with inhibition of hepatic gluconeogenesis.
The inhibition of gluconeogenesis induced by p-aminophenol in isolated renal tubules preceded severe tubular necrosis (Green et al., 1969) , and is a further manifestation of its organ selectivity. C. A. Crowe, I. C. Calder, N. P. oxidative phosphorylation and adenosine triphosphatase activity could be procured by paminophenol administered in uivo. Cytochrome bs, cytochrome P450 and cytochrome c reductase are all reduced in the kidney, but not in the liver, by p-aminophenol (Crowe, Calder, Madsen, Funder, Green, Ham & Tange, 1977) and we have shown there is decrease in kidney ATP but no effect on liver ATP.
Renal damage is clearly associated with abuse of analgesic preparations containing phenacetin, and there is consequently a strong presumption that in some way phenacetin produced renal damage. It is this presumption which gives a wider significance to the nephrotoxic effects of p-aminophenol. The nephrotoxicity of aminophenolic compounds can be related to their chemical structure (Calder, Williams, Woods, Funder, Green, Ham & Tange, 1975 ) and compounds like p-aminophenol display nephrotoxicity. This does not imply thatp-aminophenol itself is the nephrotoxic metabolite of phenacetin; but if excessive and prolonged dosage of phenacetin does produce renal damage, it is likely to do so by formation of some transient active metabolite similar to p-aminophenol.
